Swedbank Ab Biomarin Pharmaceutical Inc Transaction History

Swedbank Ab

$77.1 Billion
Q3 2024

A detailed history of Swedbank Ab transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Swedbank Ab holds 388,529 shares of BMRN stock, worth $25.5 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

388,529

Previous 288,529 34.66%

Holding current value

$25.5 Million

Previous $23.8 Million 14.97%

% of portfolio

0.04%

Previous 0.03%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$69.02 - $93.84 $6.9 Million - $9.38 Million	100,000 Added 34.66%	388,529 $27.3 Million
Q2 2024 Jul 18, 2024	SELL	$74.43 - $92.22 $565,668 - $700,872	-7,600 Reduced 2.57%	288,529 $23.8 Million
Q1 2024 May 21, 2024	BUY	$83.81 - $99.0 $24.8 Million - $29.3 Million	296,129 New	296,129 $25.9 Billion
Q4 2023 Dec 09, 2024	SELL	$76.22 - $98.51 $3.11 Million - $4.02 Million	-40,800 Reduced 8.05%	466,229 $45 Million
Q1 2023 Dec 09, 2024	BUY	$87.74 - $117.27 $5.19 Million - $6.94 Million	59,200 Added 13.22%	507,029 $49.3 Million
Q4 2022 Dec 09, 2024	BUY	$80.93 - $108.63 $2.18 Million - $2.92 Million	26,900 Added 6.39%	447,829 $46.3 Million
Q3 2022 Dec 09, 2024	SELL	$82.16 - $96.94 $8.89 Million - $10.5 Million	-108,190 Reduced 20.45%	420,929 $35.7 Million
Q2 2022 Dec 09, 2024	BUY	$71.48 - $86.85 $1.76 Million - $2.14 Million	24,661 Added 4.89%	529,119 $43.8 Million
Q1 2022 Dec 09, 2024	BUY	$74.28 - $92.69 $13.6 Million - $17 Million	183,493 Added 57.17%	504,458 $38.9 Million
Q4 2021 Dec 09, 2024	SELL	$71.72 - $91.47 $1.08 Million - $1.38 Million	-15,058 Reduced 4.48%	320,965 $28.4 Million
Q3 2021 Dec 09, 2024	BUY	$74.77 - $85.47 $14.4 Million - $16.4 Million	192,144 Added 133.55%	336,023 $26 Million
Q1 2021 Dec 09, 2024	BUY	$74.73 - $90.69 $10.8 Million - $13 Million	143,879 New	143,879 $10.9 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

News

Stay updated on Swedbank Ab with notifications on news.

Account